Previous 10 | Next 10 |
2023-08-14 10:17:31 ET Major earnings expected before the bell on Tuesday include: Cardinal Health ( CAH ) The Home Depot ( HD ) Jumia Technologies ( JMIA ) Seadrill ( SDRL ) Sea ( SE ) For further details see: Notable earnings before Tues...
FORT WORTH, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced tha...
Voriconazole Inhalation Powder (TFF VORI) is an investigational, inhaled formulation of voriconazole developed using TFF Pharmaceuticals Thin Film Freezing technology that is currently being evaluated in a Phase 2 trial for the treatment of invasive pulmonary Aspergillosis (IPA). TFF VORI is not ...
National Institute of Health/National Institute of Allergy and Infectious Disease Direct to Phase II SBIR Grant Will Fund Preclinical and IND Enabling Studies on a Shelf-Stable Mucosal Delivered Universal Flu Vaccine Using Thin Film Freezing Significant Funding a Result of a Multi-Year ...
FORT WORTH, Texas, May 23, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO H...
2023-05-11 17:49:06 ET TFF Pharmaceuticals press release ( NASDAQ: TFFP ): Q1 GAAP EPS of -$0.19 beats by $0.01 . As of March 31, 2023, TFF Pharmaceuticals reported cash and cash equivalents of $12.2 million. Shares +3.57% AH. For further details see: ...
Initial Phase 2 data for TFF VORI and TFF TAC expected later this year Expanded compassionate use program for TFF VORI Entered into CRADA with National Institute of Environmental Health Sciences Extended contract with Leidos providing additional funding for TFF’s ...
FORT WORTH, Texas, May 04, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platf...
FORT WORTH, Texas, May 01, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platf...
FORT WORTH, Texas, March 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology pla...
News, Short Squeeze, Breakout and More Instantly...
TFF Pharmaceuticals Inc - Ordinary Shares Company Name:
TFFP Stock Symbol:
NYSE Market:
TFF Pharmaceuticals Inc - Ordinary Shares Website:
FORT WORTH, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
FDA Provided Constructive Feedback to Help Guide Next Steps in TFF TAC Clinical Development Company to Provide More Detailed Regulatory Update in 3Q 2024 FORT WORTH, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a ...